???? Still checking biologics quality after the batch is done? That’s like realising your cake’s raw after your oven’s off. Real-time insights are long overdue in biopharma. ArgusEye is bringing live process sensing to biologics manufacturing. ?? Watch CEO Erik Martinsson break it down ??????
???? The biopharmaceutical industry plays a crucial role in developing vital biological drugs to treat diseases like cancer and Alzheimer’s. However, the reliance on offline analytics and the lack of real-time insights makes development and production highly complex, time-consuming, and resource-intensive. As a result, biologics remain expensive, take a long time to manufacture, and are inaccessible to many patients worldwide. At ArgusEye, we’re changing that. Our mission is to transform biopharmaceutical development and production. With over 15 years of research behind us, our patented sensor technology integrates nanoplasmonic sensing with fiber optics to deliver groundbreaking solutions. The result? Auga?—a cutting-edge sensor system platform enabling real-time, high-precision quality data on CPPs and QCAs throughout the entire bioprocess. Auga? enables continuous process and quality control, driving efficiency, sustainability, and automation in biologics manufacturing. By facilitating data-driven bioprocessing, drug development and production accelerate—helping to meet the growing demands for new biologics. Auga? streamlines operations, bringing life-saving medicines to market faster and more affordably, ultimately improving patient access. ?? Key applications of the Auga? platform include: - Product breakthrough detection during column chromatography - Real-time measurement of product titer - Monitoring of product variants and detecting known contaminants ?? Want to learn more? Join our ongoing webinar series! The first two sessions—an introduction to our technology and product breakthrough detection using AugaOne?—are available now on our website: https://lnkd.in/d_DWFEKX Upcoming sessions will cover aggregate detection, upstream applications, and rapid quantification. ?? Next session: April 2 – "Analysis of Monoclonal Antibody Aggregates Using ArgusEye’s Nanoplasmonic Sensing Technology" Don’t miss out—register today! ?? https://lnkd.in/dkgwMRwx Stay tuned on our website and LinkedIn for updates.